The Effect of Washing Red Blood Cells on Post Heart Surgery Blood Loss
Post Cardiac Surgery Blood Loss: Effect of Washing Residual Cardiopulmonary Bypass Circuit Blood Red Cells Prior to Re-infusion. A Proof of Concept Study
1 other identifier
interventional
9
1 country
1
Brief Summary
When a child undergoes heart surgery, a heart lung machine is used to keep blood flowing while the child's own heart is stopped. After surgery, a significant amount of the child's own blood is left in this machine. In the case of small children, the relative amount of blood potentially lost to the child in this way is very large. In older children, and those who have undergone less complicated surgery, this blood can all returned to the child. Giving the child back his or her own blood makes is less likely that the child will need a transfusion of donated blood. However, in younger children, or in children who have undergone more complicated surgery, most or all of this blood is thrown away. This is because of worry that returning this blood may cause bleeding, and excessive bleeding is one of the most feared complications of heart surgery. This project will explore a method whereby the red blood cells left in the heart lung machine can be returned to children without increasing the risk of bleeding. It will also carefully examine the exact causes of higher bleeding risk in children getting their own blood back so that in the future, all children can have their own blood returned at the end of surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 13, 2008
CompletedFirst Posted
Study publicly available on registry
February 27, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedApril 14, 2011
April 1, 2011
2.5 years
February 13, 2008
April 12, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total perioperative blood loss
During surgery
Secondary Outcomes (1)
Components of the hemostatic profile will be compared between groups as secondary outcome variables
24 hours
Study Arms (2)
1
ACTIVE COMPARATORResidual pump blood management post aortic cannula removal
2
EXPERIMENTALResidual pump blood management post aortic cannula removal
Interventions
Residual pump blood will be maximally hemoconcentrated by further ultrafiltation within the CPB machine. Resulting hematocrit will be approximately 0.4. The total residual pump blood volume, approximately 300ml, will be reinfused over one hour, beginning 15 minutes after removal of the aortic cross clamp. Additional protamine sulfate will be given every 30 minutes during the infusion, .03 mg/ml of residual pump blood. Procedures in this group do not deviate from current standard practice.
Eligibility Criteria
You may qualify if:
- Children between 15 and 30 kg undergoing cardiac surgery requiring cardiopulmonary bypass at British Columbia's Children's Hospital.
- All children will be between 2 and 10 years of age.
- Surgery will only involve single atriotomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BC Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Norbert Froese, MD
University of British Columbia
- STUDY DIRECTOR
John Wu
University of British Columbia
- STUDY DIRECTOR
Jacques LeBlanc
University of British Columbia
- STUDY DIRECTOR
Andrew Campbell
University of British Columbia
- STUDY DIRECTOR
Doug Salt
University of British Columbia
- STUDY DIRECTOR
Pascal Lavoie
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 13, 2008
First Posted
February 27, 2008
Study Start
February 1, 2008
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
April 14, 2011
Record last verified: 2011-04